Alzheimer's Drug Discovery Foundation (ADDF)

Alzheimer's Drug Discovery Foundation (ADDF)

The ADDF accelerates the discovery of drugs to prevent and treat Alzheimer's disease through research funding and portfolio management.

Alzheimer's Drug Discovery Foundation (ADDF)

Podrobný úvod

The Alzheimer's Drug Discovery Foundation (ADDF) is dedicated to advancing the discovery of drugs to prevent and treat Alzheimer's disease. ADDF funds research programs focused on drug development, biomarkers, and prevention strategies. In 2024, ADDF catalyzed significant breakthroughs, including major investments in scalable blood tests and the cataloging of Alzheimer's biomarkers. The foundation also marked the 10th anniversary of the Goodes Prize and celebrated the FDA approval of Kisunla (Donanemab). ADDF's diverse portfolio is one of the largest worldwide, emphasizing lifestyle interventions and innovative diagnostics.

Více
Výzkum

Kategorie

Klíčová slova

Alzheimer's Drug Discovery FoundationADDFAlzheimer's ResearchDrug DevelopmentDrug DiscoveryBiomarkersPreventionGoodes PrizeKisunlaDonanemabLifestyle InterventionsDiagnostics Accelerator

Sdílet